Efficacy and Safety of Ivermectin Against Trichuris trichiura in Preschool-aged and School-aged Children: A Randomized Controlled Dose-finding Trial
Author(s) -
David Wimmersberger,
Jean T. Coulibaly,
Jessica D. Schulz,
Maxim Puchkow,
Jörg Huwyler,
Yves K. N’Gbesso,
Jan Hattendorf,
Jennifer Keiser
Publication year - 2018
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/ciy246
Subject(s) - trichuris trichiura , ivermectin , trichuriasis , medicine , dose , placebo , anthelmintic , helminthiasis , adverse effect , trichuris , gastroenterology , immunology , veterinary medicine , helminths , ascariasis , ascaris lumbricoides , pathology , alternative medicine
Although trichuriasis affects millions of children worldwide, recommended drugs lack efficacy and new treatment options are urgently needed. Ivermectin has promising potential to complement the anthelminthic armamentarium.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom